Related Experiment Video
Updated: Jun 12, 2026
12:27
A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors
Published on: June 8, 2022
Spingolipids in Multiple Sclerosis
Silke Walter1, Klaus Fassbender
1Department of Neurology, University of the Saarland, Homburg, Germany.
Summary
Sphingolipids, like Sphingosine-1-phosphate (S1P), are key in Multiple Sclerosis (MS) inflammation. Targeting S1P pathways, such as with FTY720, offers new therapeutic strategies for MS patients.
Area of Science:
- Neuroimmunology
- Lipid Metabolism
- Central Nervous System Disorders
Background:
- Multiple Sclerosis (MS) is a chronic CNS inflammatory disease impacting young adults.
- Current MS treatments target immune suppression and T cell brain entry.
- Sphingolipids, including Sphingosine-1-phosphate (S1P), are implicated in MS pathophysiology.
Purpose of the Study:
- To review current knowledge on sphingolipid roles in MS.
- To discuss the therapeutic potential of sphingolipids in MS treatment.
Main Methods:
- Literature review of sphingolipid involvement in MS.
- Analysis of S1P receptor interactions with lymphocytes.
- Examination of FTY720 as a therapeutic S1P analogue.
Main Results:
- S1P regulates lymphocyte trafficking via T and B cell receptors.
- The S1P analogue FTY720 demonstrates therapeutic potential in MS.
- Other cell membrane lipids may also play roles in MS.
Conclusions:
- Sphingolipids are critical players in MS pathogenesis.
- Targeting sphingolipid pathways presents promising therapeutic avenues for MS.
Related Concept Videos
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:35Asymmetric Lipid Bilayer
Biological membranes show uneven distribution of different types of lipids in the inner and outer layers, resulting in transverse asymmetric membranes. The treatment of the erythrocyte membrane with the enzyme phospholipase confirmed the asymmetric nature of the lipid bilayer. The enzyme hydrolyzes lipids into fatty acids and hydrophilic groups. The phospholipase acts only on the outer layer of the membrane, while the inner layer remains intact. The phospholipase treatment resulted in 80%...
01:32Membrane Lipids
Lipids are an essential component of all biological membranes. The average lipid content in mammalian membranes is 50%, though it can be as low as 20% in the inner mitochondrial membrane or as high as 80% in the myelin sheath present around the nerve cells.
Phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, and sphingomyelin are the most common phospholipids present in mammalian membranes. At physiological pH, phosphatidylserine is negatively charged, while the other three...
Phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, and sphingomyelin are the most common phospholipids present in mammalian membranes. At physiological pH, phosphatidylserine is negatively charged, while the other three...